Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$887,417
+$69,627 QoQ
Shares Held
65,686
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $59,723,780 across 18 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
181,481 | $23,908,306 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
25,292 | $14,997,650 | |
| 3 | ZTS |
Zoetis Inc.
|
108,357 | $12,808,880 | |
| 4 | BIOA |
BioAge Labs, Inc.
|
166,224 | $2,907,257 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,230,402 | |
| 6 | VTRS |
Viatris Inc
This page
|
65,686 | $887,417 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
31,510 | $754,034 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
5,785 | $342,876 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $887,417 | 65,686 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $817,790 | 65,686 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,115,491 | 213,686 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,051,702 | 341,736 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,181,127 | 365,227 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,712,038 | 378,477 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,394,117 | 378,477 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,023,210 | 378,477 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,513,045 | 377,977 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,332,552 | 400,051 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,791,179 | 384,501 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,837,319 | 384,501 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,009,914 | 416,831 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,053,612 | 364,206 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,879,342 | 337,951 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,538,346 | 337,951 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,680,170 | 338,251 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,187,415 | 383,401 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,027,212 | 371,012 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,095,099 | 146,613 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,159,484 | 440,908 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $14,146,751 | 754,896 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||